Evidence map›Paper›PMID 21753890›Full record

ArticleInfection and drug resistance2011

Evaluation of in-vitro antibiotic susceptibility of different morphological forms of Borrelia burgdorferi.

Eva Sapi, Navroop Kaur, Samuel Anyanwu, David F Luecke, Akshita Datar, Seema Patel, Michael Rossi, Raphael B Stricker

Abstract read
In one paragraph

Article in Infection and drug resistance, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. A systematic review of Borrelia burgdorferi morphologic variants does not support a role in chronic Lyme disease.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2014
    Pooled it
  2. Resistance ofPathogens (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Genomic characterization and antibiotic susceptibility of biofilm-formingFrontiers in cellular and infection microbiology · 2025
    Article
  5. Evidence for the Presence ofMicroorganisms · 2024
    Article
  6. Secreted Metabolites fromMicroorganisms · 2024
    Article
  7. The In Vitro Antimicrobial Susceptibility ofPathogens (Basel, Switzerland) · 2023
    Review
  8. Article
  9. Review
  10. Review
  11. Persistent Borrelia burgdorferiClinical microbiology reviews · 2022
    Review
  12. Inhibition ofInternational journal of molecular sciences · 2022
    Article
  13. Microorganisms · 2022
    Article
  14. Extraction and Fractionation of Bioactives fromPharmaceuticals (Basel, Switzerland) · 2022
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Eva SapiLyme Disease Research Group, Department of Biology and Environmental Sciences, University of New Haven, New Haven, CT, USA;
Navroop Kaur
Samuel Anyanwu
David F Luecke
Akshita Datar
Seema Patel
Michael Rossi
Raphael B Stricker

Funding

TISSUE CULTURE MODEL FOR RETINITIS PIGMENTOSA--A MOLECULAR APPROACHR25GM058268 · NIGMS · MOREHOUSE SCHOOL OF MEDICINE · PI HARRIS-HOOKER, SANDRA, STILES, JONATHAN K. · 1998 to 2023
$16.5M
NIGMS NIH HHS R25 GM058268
6 · The paper itself

Abstract

backgroundLyme disease is a tick-borne illness caused by the spirochete Borrelia burgdorferi. Although antibiotic therapy is usually effective early in the disease, relapse may occur when administration of antibiotics is discontinued. Studies have suggested that resistance and recurrence of Lyme disease might be due to formation of different morphological forms of B. burgdorferi, namely round bodies (cysts) and biofilm-like colonies. Better understanding of the effect of antibiotics on all morphological forms of B. burgdorferi is therefore crucial to provide effective therapy for Lyme disease.

methodsThree morphological forms of B. burgdorferi (spirochetes, round bodies, and biofilm-like colonies) were generated using novel culture methods. Minimum inhibitory concentration and minimum bactericidal concentration of five antimicrobial agents (doxycycline, amoxicillin, tigecycline, metronidazole, and tinidazole) against spirochetal forms of B. burgdorferi were evaluated using the standard published microdilution technique. The susceptibility of spirochetal and round body forms to the antibiotics was then tested using fluorescent microscopy (BacLight™ viability staining) and dark field microscopy (direct cell counting), and these results were compared with the microdilution technique. Qualitative and quantitative effects of the antibiotics against biofilm-like colonies were assessed using fluorescent microscopy and dark field microscopy, respectively.

resultsDoxycycline reduced spirochetal structures ∼90% but increased the number of round body forms about twofold. Amoxicillin reduced spirochetal forms by ∼85%-90% and round body forms by ∼68%, while treatment with metronidazole led to reduction of spirochetal structures by ∼90% and round body forms by ∼80%. Tigecycline and tinidazole treatment reduced both spirochetal and round body forms by ∼80%-90%. When quantitative effects on biofilm-like colonies were evaluated, the five antibiotics reduced formation of these colonies by only 30%-55%. In terms of qualitative effects, only tinidazole reduced viable organisms by ∼90%. Following treatment with the other antibiotics, viable organisms were detected in 70%-85% of the biofilm-like colonies.

conclusionAntibiotics have varying effects on the different morphological forms of B. burgdorferi. Persistence of viable organisms in round body forms and biofilm-like colonies may explain treatment failure and persistent symptoms following antibiotic therapy of Lyme disease.

Indexed as

biofilmscystsLyme diseaseround bodiesspirochetes

Identifiers

PMID21753890
PMCPMC3132871

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.